首页>European journal of cancer care>Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: Expanded access programme data from Belgium (the TRUST study)
Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: Expanded access programme data from Belgium (the TRUST study)
作者单位：Thoracic Oncology, Ghent University Hospital, Gent, Belgium[1]Center for Health Outcomes and Pharmacoeconomic Research, College of Pharmacy, University of[2]Department of Respiratory Medicine, ZNA Middelheim, Antwerpen, Belgium[3]Department of Respiratory Medicine, Centre Hospitalier Régional de la Citadelle, Liège, Belgium[4]Roche, Brussel, Belgium[5]
换一批
